symmetric dimethylarginine has been researched along with Critical Illness in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fraites, T; Köster, LS; Peda, A; Sithole, F | 1 |
| Bruensing, J; Buendgens, L; Dückers, H; Koch, A; Kunze, J; Luedde, T; Matthes, M; Tacke, F; Trautwein, C; Weiskirchen, R | 1 |
2 other study(ies) available for symmetric dimethylarginine and Critical Illness
| Article | Year |
|---|---|
A preliminary investigation into the prognostic relevance of symmetric dimethylarginine in critically ill dogs.
Topics: Acute Kidney Injury; Animals; Arginine; Biomarkers; Case-Control Studies; Critical Illness; Dog Diseases; Dogs; Female; Male; Predictive Value of Tests; Prognosis; Prospective Studies | 2018 |
Regulation and prognostic relevance of symmetric dimethylarginine serum concentrations in critical illness and sepsis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Arginine; Biomarkers; Critical Care; Critical Illness; Female; Gene Expression Regulation; Humans; Inflammation; Male; Middle Aged; Multiple Organ Failure; Multivariate Analysis; Prognosis; Regression Analysis; Risk Factors; Sepsis; Young Adult | 2013 |